Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Maryland, Baltimore
- The Ohio State University
- The University of Arizona
- Stanford University
- Aarhus University
- Carnegie Mellon University
- Ghent University
- Institute for bioengineering of Catalonia, IBEC
- National Institute of Research and Innovation
- South Dakota Mines
- UNIVERSIDAD DE ZARAGOZA
- University of Miami
- University of Warsaw
- CHU Clermont-Ferrand
- Chalmers University of Technology
- ETH Zürich
- Empa
- European Synchrotron Radiation Facility
- FAPESP - São Paulo Research Foundation
- Grenoble INP - Institute of Engineering
- Institut Pasteur
- Iowa State University
- Johns Hopkins University
- King's College London
- Koç University
- Lunds universitet
- Maimonides Biomedical Research Institute of Cordoba - IMIBIC
- Max Planck Institute for Chemistry, Mainz
- Max Planck Institute for Extraterrestrial Physics, Garching
- National Institute of Research and Innovation
- New York University
- Pennsylvania State University
- Polymer Institute of the Slovak Academy of Sciences
- Rutgers University
- SciLifeLab
- St Jude Children's Research Hospital
- The University of Iowa
- Umeå University
- Universitat Rovira i Virgili
- Universite de Montpellier
- University of Florida
- University of Jyväskylä
- University of Lille
- University of Liverpool
- University of Liverpool;
- University of Lund
- University of Minnesota
- University of North Carolina at Chapel Hill
- University of Oxford
- Universität Duisburg Essen
- Université Côte d'Azur
- Łukasiewicz Research Network - Krakow Institute of Technology
- 42 more »
- « less
-
Field
-
immunotherapy interventions targeting CD4+ T cells based on recombinant monoclonal antibodies or mRNA-containing lipid nanoparticles. The project will be primarily developed in a pre-clinical murine model of lung
-
, Water Transport Assays, Self-Assembly, Cell Culture, Assay Development, Proteomics, Western Blot, Synthetic Inorganic Chemistry, Lipid Nanoparticles. About the role The Project In this project
-
on developing a microfluidic technology for loading molecules and nanoparticles into red blood cells ex vivo, with the goal of leveraging red blood cells as a biocompatible drug depot for extended release. The
-
development of new sensors, support nanoparticle-based cellular reprogramming strategies and identify new omics-based biomarkers. We work closely with clinical partners and we focus on deep understanding
-
on developing a microfluidic technology for loading molecules and nanoparticles into red blood cells ex vivo, with the goal of leveraging red blood cells as a biocompatible drug depot for extended release. The
-
. Research topics within the pharma part includes lipid nanoparticles for RNA delivery, protein corona formation on LNPs therapeutic protein formulations, protein interaction with excipients and drying and dry
-
The Division of Food and Pharma conducts research both within food science and pharmaceutical technology. Research topics within the pharma part includes lipid nanoparticles for RNA delivery, protein corona
-
biobanks in the country, enabling studies across diverse cardiovascular genotypes. A key component of this role includes applying advanced nanoparticle technology to track single GPCR molecules in
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
service. Position Summary We are looking for a highly motivated postdoctoral associate/s with a strong background in extracellular vesicles, nanoparticle preparation, and protein production. The successful
-
are motivated to learn EV and small-RNA methods are explicitly encouraged to apply. Required qualifications PhD degree in Plant Science, Plant Physiology, Plant Molecular Biology, Microbiology or a related